Marc-antoine A. Benderra
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments-A VigiBase Disproportionality Analysis Study.
Journal: Clinical pharmacology and therapeutics
Published: March 22, 2026
Darolutamide plus androgene-deprivation therapy in hormone-sensitive metastatic prostate cancer
Journal: Bulletin du cancer
Published: October 04, 2025
Multicenter Retrospective Analysis of the Safety and Efficacy of Sacituzumab Govitecan Combined With Radiation Therapy: The French ATTENTION Study.
Journal: International journal of radiation oncology, biology, physics
Published: June 11, 2025
Oncotype Dx Breast Cancer Assay in Older Patients: A Real Life Cohort.
Journal: Cancer medicine
Published: May 27, 2025
Safety and efficacy of combined trastuzumab-deruxtecan and concurrent radiation therapy in breast cancer. The TENDANCE multicentric French study.
Journal: Breast (Edinburgh, Scotland)
Published: December 17, 2024
Prediction of moderate and severe toxicities of chemotherapy in older patients with cancer: a propensity weighted analysis of ELCAPA cohort.
Journal: The oncologist
Published: March 12, 2024
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.
Journal: Bulletin du cancer
Published: December 07, 2023
Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
Journal: Cancer medicine
Published: October 27, 2023
Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study.
Journal: Cancer medicine
Published: July 18, 2023
COVID-19 mortality: are comorbidities, socio-economic status and ethnicity more important than cancer?
Journal: Annals of translational medicine
Published: November 10, 2022
Immune-related generalised oedema - A new category of adverse events with immune checkpoint inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 10, 2022
Last Updated: 09/26/2026